Small cells in hepatoblastoma lack "oval" cell phenotype

Sunil Badve, L. Logdberg, A. Lal, M. T.G. De Davila, M. A. Greco, S. Mitsudo, R. Saxena

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Hepatoblastoma, a childhood tumor of the liver, is composed of epithelial and mesenchymal elements in varying proportions and at various stages of differentiation. The epithelial element recapitulates the stages of hepatocyte development from the primitive blastema through embryonal hepatocytes to fetal hepatocytes. The blastemal or undifferentiated cells have been postulated to represent neoplastic hepatocyte progenitor cells. In this study, we examine the immunophenotype of the various epithelial cells of hepatoblastoma with special emphasis on the small undifferentiated cell component and compare it with that of adult hepatocytes and hepatic stem (oval) cells. Putative stem cells in the liver can express all of the following markers: α-feto protein, CK19 (OV-6), chromogranin A, Bcl-2, HepPar-1, and α1 microglobulin. The latter, like α-feto protein, is a plasma protein synthesized by hepatocytes. Both α1 microglobulin and HepPar-1 are expressed in fetal liver cells as early as 7 weeks of intrauterine fife. They are also expressed in hepatocellular carcinoma and in hepatocytic cell lines derived from normal fetal or adult liver. Formalin-fixed, paraffin-embedded archival tissues from 10 predominantly epithelial hepatoblastomas were immunostained with antibodies directed against CD 34, α1 microglobulin, Bcl-2, HepPar 1, and CK19 using the avidin-biotin-peroxidase method. The undifferentiated small cell component did not express any of the markers studied, namely, Bcl-2, HepPar-1, α1 microglobulin, CD34, or CK19. Hepatocyte-like cells were α1 microglobulin- and HepPar-1-positive, with the intensity of staining correlating with the degree of hepatocytic differentiation. Bcl-2 expression was restricted to areas of ductular differentiation. CK19 was detected in foci that showed duct formation. The small cells of hepatoblastoma did not express HepPar-1, Bcl-2, CK19, α1 microglobulin, or CD34, markers that characterize the immunophenotype of hepatic stem cells ("oval" cells). Thus, this observation raises the following questions: (1) is "hepatoblastoma" a misnomer? (2) is the expression of tumor antigens dysregulated in hepatoblastoma? (3) does the liver have two different types of progenitor cells, oval cells and blastemal cells, with differing immunophenotypes? and (4) do the blastemal cells, rather than oval cells, represent the more primitive progenitor cells of the liver?

Original languageEnglish (US)
Pages (from-to)930-936
Number of pages7
JournalModern Pathology
Volume16
Issue number9
DOIs
StatePublished - Sep 1 2003

Fingerprint

Hepatoblastoma
Hepatocytes
Phenotype
Stem Cells
Liver
Cellular Structures
Chromogranin A
Avidin
Neoplasm Antigens
Biotin
Paraffin
Formaldehyde
Peroxidase
Blood Proteins
Hepatocellular Carcinoma
Proteins
Epithelial Cells
Staining and Labeling
Cell Line

Keywords

  • Hepatoblastoma
  • Liver neoplasms
  • Oval cells
  • Progenitor cells
  • Stem cells

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Badve, S., Logdberg, L., Lal, A., De Davila, M. T. G., Greco, M. A., Mitsudo, S., & Saxena, R. (2003). Small cells in hepatoblastoma lack "oval" cell phenotype. Modern Pathology, 16(9), 930-936. https://doi.org/10.1097/01.MP.0000086486.52370.81

Small cells in hepatoblastoma lack "oval" cell phenotype. / Badve, Sunil; Logdberg, L.; Lal, A.; De Davila, M. T.G.; Greco, M. A.; Mitsudo, S.; Saxena, R.

In: Modern Pathology, Vol. 16, No. 9, 01.09.2003, p. 930-936.

Research output: Contribution to journalArticle

Badve, S, Logdberg, L, Lal, A, De Davila, MTG, Greco, MA, Mitsudo, S & Saxena, R 2003, 'Small cells in hepatoblastoma lack "oval" cell phenotype', Modern Pathology, vol. 16, no. 9, pp. 930-936. https://doi.org/10.1097/01.MP.0000086486.52370.81
Badve S, Logdberg L, Lal A, De Davila MTG, Greco MA, Mitsudo S et al. Small cells in hepatoblastoma lack "oval" cell phenotype. Modern Pathology. 2003 Sep 1;16(9):930-936. https://doi.org/10.1097/01.MP.0000086486.52370.81
Badve, Sunil ; Logdberg, L. ; Lal, A. ; De Davila, M. T.G. ; Greco, M. A. ; Mitsudo, S. ; Saxena, R. / Small cells in hepatoblastoma lack "oval" cell phenotype. In: Modern Pathology. 2003 ; Vol. 16, No. 9. pp. 930-936.
@article{66b0f65ea5b44beabd9e91331b1152a6,
title = "Small cells in hepatoblastoma lack {"}oval{"} cell phenotype",
abstract = "Hepatoblastoma, a childhood tumor of the liver, is composed of epithelial and mesenchymal elements in varying proportions and at various stages of differentiation. The epithelial element recapitulates the stages of hepatocyte development from the primitive blastema through embryonal hepatocytes to fetal hepatocytes. The blastemal or undifferentiated cells have been postulated to represent neoplastic hepatocyte progenitor cells. In this study, we examine the immunophenotype of the various epithelial cells of hepatoblastoma with special emphasis on the small undifferentiated cell component and compare it with that of adult hepatocytes and hepatic stem (oval) cells. Putative stem cells in the liver can express all of the following markers: α-feto protein, CK19 (OV-6), chromogranin A, Bcl-2, HepPar-1, and α1 microglobulin. The latter, like α-feto protein, is a plasma protein synthesized by hepatocytes. Both α1 microglobulin and HepPar-1 are expressed in fetal liver cells as early as 7 weeks of intrauterine fife. They are also expressed in hepatocellular carcinoma and in hepatocytic cell lines derived from normal fetal or adult liver. Formalin-fixed, paraffin-embedded archival tissues from 10 predominantly epithelial hepatoblastomas were immunostained with antibodies directed against CD 34, α1 microglobulin, Bcl-2, HepPar 1, and CK19 using the avidin-biotin-peroxidase method. The undifferentiated small cell component did not express any of the markers studied, namely, Bcl-2, HepPar-1, α1 microglobulin, CD34, or CK19. Hepatocyte-like cells were α1 microglobulin- and HepPar-1-positive, with the intensity of staining correlating with the degree of hepatocytic differentiation. Bcl-2 expression was restricted to areas of ductular differentiation. CK19 was detected in foci that showed duct formation. The small cells of hepatoblastoma did not express HepPar-1, Bcl-2, CK19, α1 microglobulin, or CD34, markers that characterize the immunophenotype of hepatic stem cells ({"}oval{"} cells). Thus, this observation raises the following questions: (1) is {"}hepatoblastoma{"} a misnomer? (2) is the expression of tumor antigens dysregulated in hepatoblastoma? (3) does the liver have two different types of progenitor cells, oval cells and blastemal cells, with differing immunophenotypes? and (4) do the blastemal cells, rather than oval cells, represent the more primitive progenitor cells of the liver?",
keywords = "Hepatoblastoma, Liver neoplasms, Oval cells, Progenitor cells, Stem cells",
author = "Sunil Badve and L. Logdberg and A. Lal and {De Davila}, {M. T.G.} and Greco, {M. A.} and S. Mitsudo and R. Saxena",
year = "2003",
month = "9",
day = "1",
doi = "10.1097/01.MP.0000086486.52370.81",
language = "English (US)",
volume = "16",
pages = "930--936",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Small cells in hepatoblastoma lack "oval" cell phenotype

AU - Badve, Sunil

AU - Logdberg, L.

AU - Lal, A.

AU - De Davila, M. T.G.

AU - Greco, M. A.

AU - Mitsudo, S.

AU - Saxena, R.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Hepatoblastoma, a childhood tumor of the liver, is composed of epithelial and mesenchymal elements in varying proportions and at various stages of differentiation. The epithelial element recapitulates the stages of hepatocyte development from the primitive blastema through embryonal hepatocytes to fetal hepatocytes. The blastemal or undifferentiated cells have been postulated to represent neoplastic hepatocyte progenitor cells. In this study, we examine the immunophenotype of the various epithelial cells of hepatoblastoma with special emphasis on the small undifferentiated cell component and compare it with that of adult hepatocytes and hepatic stem (oval) cells. Putative stem cells in the liver can express all of the following markers: α-feto protein, CK19 (OV-6), chromogranin A, Bcl-2, HepPar-1, and α1 microglobulin. The latter, like α-feto protein, is a plasma protein synthesized by hepatocytes. Both α1 microglobulin and HepPar-1 are expressed in fetal liver cells as early as 7 weeks of intrauterine fife. They are also expressed in hepatocellular carcinoma and in hepatocytic cell lines derived from normal fetal or adult liver. Formalin-fixed, paraffin-embedded archival tissues from 10 predominantly epithelial hepatoblastomas were immunostained with antibodies directed against CD 34, α1 microglobulin, Bcl-2, HepPar 1, and CK19 using the avidin-biotin-peroxidase method. The undifferentiated small cell component did not express any of the markers studied, namely, Bcl-2, HepPar-1, α1 microglobulin, CD34, or CK19. Hepatocyte-like cells were α1 microglobulin- and HepPar-1-positive, with the intensity of staining correlating with the degree of hepatocytic differentiation. Bcl-2 expression was restricted to areas of ductular differentiation. CK19 was detected in foci that showed duct formation. The small cells of hepatoblastoma did not express HepPar-1, Bcl-2, CK19, α1 microglobulin, or CD34, markers that characterize the immunophenotype of hepatic stem cells ("oval" cells). Thus, this observation raises the following questions: (1) is "hepatoblastoma" a misnomer? (2) is the expression of tumor antigens dysregulated in hepatoblastoma? (3) does the liver have two different types of progenitor cells, oval cells and blastemal cells, with differing immunophenotypes? and (4) do the blastemal cells, rather than oval cells, represent the more primitive progenitor cells of the liver?

AB - Hepatoblastoma, a childhood tumor of the liver, is composed of epithelial and mesenchymal elements in varying proportions and at various stages of differentiation. The epithelial element recapitulates the stages of hepatocyte development from the primitive blastema through embryonal hepatocytes to fetal hepatocytes. The blastemal or undifferentiated cells have been postulated to represent neoplastic hepatocyte progenitor cells. In this study, we examine the immunophenotype of the various epithelial cells of hepatoblastoma with special emphasis on the small undifferentiated cell component and compare it with that of adult hepatocytes and hepatic stem (oval) cells. Putative stem cells in the liver can express all of the following markers: α-feto protein, CK19 (OV-6), chromogranin A, Bcl-2, HepPar-1, and α1 microglobulin. The latter, like α-feto protein, is a plasma protein synthesized by hepatocytes. Both α1 microglobulin and HepPar-1 are expressed in fetal liver cells as early as 7 weeks of intrauterine fife. They are also expressed in hepatocellular carcinoma and in hepatocytic cell lines derived from normal fetal or adult liver. Formalin-fixed, paraffin-embedded archival tissues from 10 predominantly epithelial hepatoblastomas were immunostained with antibodies directed against CD 34, α1 microglobulin, Bcl-2, HepPar 1, and CK19 using the avidin-biotin-peroxidase method. The undifferentiated small cell component did not express any of the markers studied, namely, Bcl-2, HepPar-1, α1 microglobulin, CD34, or CK19. Hepatocyte-like cells were α1 microglobulin- and HepPar-1-positive, with the intensity of staining correlating with the degree of hepatocytic differentiation. Bcl-2 expression was restricted to areas of ductular differentiation. CK19 was detected in foci that showed duct formation. The small cells of hepatoblastoma did not express HepPar-1, Bcl-2, CK19, α1 microglobulin, or CD34, markers that characterize the immunophenotype of hepatic stem cells ("oval" cells). Thus, this observation raises the following questions: (1) is "hepatoblastoma" a misnomer? (2) is the expression of tumor antigens dysregulated in hepatoblastoma? (3) does the liver have two different types of progenitor cells, oval cells and blastemal cells, with differing immunophenotypes? and (4) do the blastemal cells, rather than oval cells, represent the more primitive progenitor cells of the liver?

KW - Hepatoblastoma

KW - Liver neoplasms

KW - Oval cells

KW - Progenitor cells

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=0141853364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141853364&partnerID=8YFLogxK

U2 - 10.1097/01.MP.0000086486.52370.81

DO - 10.1097/01.MP.0000086486.52370.81

M3 - Article

C2 - 13679457

AN - SCOPUS:0141853364

VL - 16

SP - 930

EP - 936

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 9

ER -